Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole pretreatment for myocardial protection in elective CABG
NL-OMON33210Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dipyridamole in myocardial ischemia-reperfusion injury (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Troponin-I levels. Started Jan 2010; status: active, not recruiting.
02
Drugs
dipyridamole
03
Conditions
myocardial ischemia-reperfusion injury
Beyond the preview
Go deeper on NL-OMON33210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33210.